UnknownNCT00583193
Duloxetine Monotherapy in the Treatment of PTSD
This study has an unknown status in the United States. It focuses on PTSD.
In United StatesPTSDDrugA study involving a medication or substance.Over 18 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT01338818
Extension Evaluating Methylphenidate Hydrochloride Extended Release in Adults With Attention Deficit/Hyperactivity Disorder
This study is completed in the United States, in Belgium, in Colombia, .... It focuses on ADHD.
In United StatesADHDDrugFrom 18 Years to 60 Years
CompletedNCT04143217
Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD
This study is completed in the United States. It focuses on ADHD.
In United StatesADHDDrugFrom 18 Years to 65 Years
CompletedNCT02050854
Safety study of pharmacokinetics of Aripiprazole in schizophrenia
This study is completed in the United States. It is testing pharmacokinetics of Aripiprazole for schizophrenia.
In United StatesBipolarity, SchizophreniaOtherFrom 18 Years to 55 Years
CompletedNCT06235905
Of SPN-820 in Adults With Major Depressive Disorder
This study is completed in the United States. It focuses on depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
CompletedNCT00586573
Study of Namenda in Adult Subjects With ADHD and ADHD NOS
This study is completed in the United States. It is testing namenda for ADHD.
In United StatesADHDDrugFrom 18 Years to 55 Years
CompletedNCT06185985
Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
This study is completed in the United States. It focuses on ADHD.
Remote / onlineADHDDrugOver 18 Years
CompletedNCT02160262
Safety Study in Adults With ADHD
This study is completed in the United States. It focuses on ADHD.
In United StatesADHDDrugFrom 18 Years to 55 Years
TerminatedNCT04634669
Safety study of AXS-05 in Depression
This study was terminated in the United States. It is testing AXS-05 for Depression.
In United StatesDepressionDrugOver 18 Years
Enrolling By InvitationNCT06878976
Safety study of solriamfetol in Eating disorders
This study is enrolling by invitation in the United States. It is testing solriamfetol for Eating disorders.
In United StatesEating disordersDrugFrom 18 Years to 56 Years
TerminatedNCT05030350
Safety study of PH94B in Social Anxiety Disorder (SAD)
This study was terminated in the United States. It focuses on anxiety.
In United StatesAnxietyDrugFrom 18 Years to 65 Years
CompletedNCT01875822
Study of Curcumin C-3 Complex in Schizophrenia
This study is completed in the United States. It is testing Curcumin C-3 Complex for schizophrenia.
Broader resultSchizophrenia, DepressionOtherFrom 18 Years to 65 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.